CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Clarient, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Clarient, Inc.
31 Columbia
Phone: (949) 425-5700p:949 425-5700 Aliso Viejo, CA  92656  United States Fax: (949) 425-5701f:949 425-5701
This company was Merged or Acquired on 12/30/2015.
This company ceased filing statements with the SEC on 1/12/2011.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
Clarient, Inc. (Clarient) is an oncology diagnostics services company. It provides diagnostic services that assess and characterize cancer for physicians treating their patients, as well as for biopharmaceutical companies in the process of clinically testing various therapies. As of December 31, 2009, its services were provided within the United States. Clarient provides a range of oncology diagnostic testing and consultative services, which include technical laboratory services and interpretation of laboratory test results by physicians that specialize in pathology, such reports and analyses primarily are provided to it customers through its Internet-based portal, PATHSiTE.
(Source: 10-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/201012/31/2009YesYes--Yes

Industries
SIC Code Description
8071 Medical laboratories

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board James A.Datin 48 7/18/2006 10/18/2005
Chief Executive Officer Ronald A.Andrews 50 12/22/2010 7/22/2004
President, Chief Operating Officer Michael J.Pellini 44 3/26/2009 6/27/2007
7 additional Officers and Directors records available in full report.

Business Names
Business Name
Applied Genomics, Inc.
ChromaVision International, Inc.
Clarient Diagnostic Services, Inc.
Clarient, Inc.

General Information
Stock Exchange: NASD
Federal Tax Id: 752649072
Fax Number: (949) 425-5701
Email Address: InvestorRelations@chromavision.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023